SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-21-009545
Filing Date
2021-07-29
Accepted
2021-07-29 07:15:55
Documents
13
Period of Report
2021-07-29
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bpmc-20210729x8k.htm   iXBRL 8-K 40709
2 EX-99.1 bpmc-20210729xex99d1.htm EX-99.1 114130
  Complete submission text file 0001558370-21-009545.txt   284691

Data Files

Seq Description Document Type Size
3 EX-101.SCH bpmc-20210729.xsd EX-101.SCH 3186
4 EX-101.LAB bpmc-20210729_lab.xml EX-101.LAB 15248
5 EX-101.PRE bpmc-20210729_pre.xml EX-101.PRE 9847
6 EXTRACTED XBRL INSTANCE DOCUMENT bpmc-20210729x8k_htm.xml XML 4673
Mailing Address 45 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 45 SIDNEY STREET CAMBRIDGE MA 02139 617-374-7580
Blueprint Medicines Corp (Filer) CIK: 0001597264 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37359 | Film No.: 211124801
SIC: 2834 Pharmaceutical Preparations